{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T12:24:31Z","timestamp":1777983871175,"version":"3.51.4"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Finnish State Research Funding"},{"DOI":"10.13039\/501100004012","name":"Jane ja Aatos Erkon S\u00e4\u00e4ti\u00f6","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004012","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100010711","name":"Sy\u00f6p\u00e4s\u00e4\u00e4ti\u00f6","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100010711","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100006306","name":"Sigrid Jus\u00e9liuksen S\u00e4\u00e4ti\u00f6","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006306","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"crossref"}]},{"name":"iCAN Precision Medicine Flagship of the Academy of Finland"},{"DOI":"10.13039\/501100019783","name":"Relander Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100019783","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100008413","name":"Instrumentariumin Tiedes\u00e4\u00e4ti\u00f6","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008413","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100015738","name":"Mary och Georg C. Ehrnrooths Stiftelse","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100015738","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004756","name":"Emil Aaltosen S\u00e4\u00e4ti\u00f6","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004756","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-42097-8","type":"journal-article","created":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T12:10:32Z","timestamp":1772453432000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Quantitative analysis of myeloid cell patterns and immunosuppressive enzyme (IDO, ARG1) expression in colorectal cancer pulmonary metastases and corresponding primary tumours"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2342-6034","authenticated-orcid":false,"given":"Topias","family":"Karjula","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanna","family":"Elomaa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara A.","family":"V\u00e4yrynen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vesa-Matti","family":"Pohjanen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maarit","family":"Ahtiainen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"B\u00f6hm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jukka-Pekka","family":"Mecklin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erkki-Ville","family":"Wirta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toni T.","family":"Sepp\u00e4l\u00e4","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eero","family":"Sihvo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fredrik","family":"Yannopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olli","family":"Helminen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juha P.","family":"V\u00e4yrynen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,2]]},"reference":[{"issue":"10","key":"42097_CR1","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1038\/nm934","volume":"9","author":"C Uyttenhove","year":"2003","unstructured":"Uyttenhove, C. et al. Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase. Nat. Med. 9(10), 1269\u201374 (2003).","journal-title":"Nat. Med."},{"issue":"11","key":"42097_CR2","doi-asserted-by":"publisher","first-page":"6752","DOI":"10.4049\/jimmunol.176.11.6752","volume":"176","author":"F Fallarino","year":"2006","unstructured":"Fallarino, F. et al. The Combined Effects of Tryptophan Starvation and Tryptophan Catabolites Down-Regulate T Cell Receptor \u03b6-Chain and Induce a Regulatory Phenotype in Naive T Cells. The J. Immunol. 176(11), 6752\u201361 (2006).","journal-title":"The J. Immunol."},{"issue":"3","key":"42097_CR3","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1111\/j.1476-5381.2009.00291.x","volume":"158","author":"M Munder","year":"2009","unstructured":"Munder, M. Arginase: An emerging key player in the mammalian immune system: Review. Br. J. Pharmacol. 158(3), 638\u201351 (2009).","journal-title":"Br. J. Pharmacol."},{"issue":"4\u20135","key":"42097_CR4","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.clinbiochem.2008.11.018","volume":"42","author":"W Grabo\u0144","year":"2009","unstructured":"Grabo\u0144, W., Mielczarek-Puta, M., Chrzanowska, A. & Bara\u0144czyk-Ku\u017ama, A. L-arginine as a factor increasing arginase significance in diagnosis of primary and metastatic colorectal cancer. Clin. Biochem. 42(4\u20135), 353\u20137 (2009).","journal-title":"Clin. Biochem."},{"key":"42097_CR5","doi-asserted-by":"crossref","unstructured":"Grzywa TM, Sosnowska A, Matryba P, Rydzynska Z, Jasinski M, Nowis D, et al. Myeloid Cell-Derived Arginase in Cancer Immune Response. Front. Immunol. Front. Media 11 (2020).","DOI":"10.3389\/fimmu.2020.00938"},{"key":"42097_CR6","doi-asserted-by":"crossref","unstructured":"Meireson A, Devos M, Brochez L. IDO Expression in Cancer: Different Compartment, Different Functionality? Front. Immunol. 11 (2020).","DOI":"10.3389\/fimmu.2020.531491"},{"issue":"6","key":"42097_CR7","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1182\/blood-2004-07-2521","volume":"105","author":"M Munder","year":"2005","unstructured":"Munder, M. Arginase I is constitutively expressed in human granulocytes and participates in fungicidal activity. Blood 105(6), 2549\u201356 (2005).","journal-title":"Blood"},{"key":"42097_CR8","doi-asserted-by":"crossref","unstructured":"Lorentzen CL, Martinenaite E, Kjeldsen JW, Holmstroem RB, M\u00f8rk SK, Pedersen AW, et al. Arginase-1 targeting peptide vaccine in patients with metastatic solid tumors \u2013 A phase I trial. Front Immunol. 13 (2022).","DOI":"10.3389\/fimmu.2022.1023023"},{"key":"42097_CR9","doi-asserted-by":"crossref","unstructured":"Naing A, Papadopoulos KP, Pishvaian MJ, Rahma O, Hanna GJ, Garralda E, et al. First-in-human phase 1 study of the arginase inhibitor INCB001158 alone or combined with pembrolizumab in patients with advanced or metastatic solid tumours. BMJ Oncol. 3(1) (2024).","DOI":"10.1136\/bmjonc-2023-000249"},{"issue":"8","key":"42097_CR10","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/S1470-2045(19)30274-8","volume":"20","author":"GV Long","year":"2019","unstructured":"Long, G. V. et al. Epacadostat plus pembrolizumab versus placebo plus pembrolizumab in patients with unresectable or metastatic melanoma (ECHO-301\/KEYNOTE-252): a phase 3, randomised, double-blind study. Lancet Oncol. 20(8), 1083\u201397 (2019).","journal-title":"Lancet Oncol."},{"issue":"3","key":"42097_CR11","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 74(3), 229\u201363 (2024).","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"42097_CR12","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/bjc.2011.513","volume":"106","author":"L Ferdinande","year":"2012","unstructured":"Ferdinande, L. et al. Clinicopathological significance of indoleamine 2,3-dioxygenase 1 expression in colorectal cancer. Br. J. Cancer 106(1), 141\u20137 (2012).","journal-title":"Br. J. Cancer"},{"issue":"20","key":"42097_CR13","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.3748\/wjg.v24.i20.2181","volume":"24","author":"WJ Ma","year":"2018","unstructured":"Ma, W. J. et al. Indoleamine-2,3-dioxygenase 1\/cyclooxygenase 2 expression prediction for adverse prognosis in colorectal cancer. World J. Gastroenterol. 24(20), 2181\u201390 (2018).","journal-title":"World J. Gastroenterol."},{"issue":"6","key":"42097_CR14","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1007\/s00432-018-2620-x","volume":"144","author":"SJ Lee","year":"2018","unstructured":"Lee, S. J. et al. CD274, LAG3, and IDO1 expressions in tumor-infiltrating immune cells as prognostic biomarker for patients with MSI-high colon cancer. J. Cancer Res. Clin. Oncol. 144(6), 1005\u201314 (2018).","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"4","key":"42097_CR15","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s00262-019-02306-y","volume":"68","author":"J Schollbach","year":"2019","unstructured":"Schollbach, J. et al. Prognostic value of tumour-infiltrating CD8 + lymphocytes in rectal cancer after neoadjuvant chemoradiation: is indoleamine-2,3-dioxygenase (IDO1) a friend or foe?. Cancer Immunol. Immunother. 68(4), 563\u201375 (2019).","journal-title":"Cancer Immunol. Immunother."},{"issue":"6","key":"42097_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2019.03.012","volume":"215","author":"Z Ma","year":"2019","unstructured":"Ma, Z. et al. Overexpression of Arginase-1 is an indicator of poor prognosis in patients with colorectal cancer. Pathol. Res. Pract. 215(6), 152383 (2019).","journal-title":"Pathol. Res. Pract."},{"key":"42097_CR17","doi-asserted-by":"crossref","unstructured":"Elomaa H, H\u00e4rk\u00f6nen J, V\u00e4yrynen SA, Ahtiainen M, Ogino S, Nowak JA, et al. Quantitative Multiplexed Analysis of Indoleamine 2,3-Dioxygenase (IDO) and Arginase-1 (ARG1) Expression and Myeloid Cell Infiltration in Colorectal Cancer. Modern Pathol. 37(4) (2024).","DOI":"10.1016\/j.modpat.2024.100450"},{"issue":"6","key":"42097_CR18","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1097\/SLA.0000000000001351","volume":"263","author":"SA Pugh","year":"2016","unstructured":"Pugh, S. A. et al. Site and stage of colorectal cancer influence the likelihood and distribution of disease recurrence and postrecurrence survival data from the FACS randomized controlled trial. Ann. Surg. 263(6), 1143\u20137 (2016).","journal-title":"Ann. Surg."},{"issue":"4","key":"42097_CR19","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1002\/bjs5.50299","volume":"4","author":"V V\u00e4yrynen","year":"2020","unstructured":"V\u00e4yrynen, V. et al. Incidence and management of patients with colorectal cancer and synchronous and metachronous colorectal metastases: a population-based study. BJS Open. 4(4), 685 (2020).","journal-title":"BJS Open."},{"key":"42097_CR20","unstructured":"Colorectal Cancer Survival Rates | Colorectal Cancer Prognosis. https:\/\/www.cancer.org\/cancer\/colon-rectal-cancer\/detection-diagnosis-staging\/survival-rates.html (2021)."},{"key":"42097_CR21","doi-asserted-by":"crossref","unstructured":"Brierley JD, Gospodarowicz MK, Wittekind C. TNM Classification of Malignant Tumours, 8th edition. Brierley JD, Gospodarowicz MK, Wittekind C, (ed). (2016).","DOI":"10.1002\/9780471420194.tnmc26.pub3"},{"issue":"1","key":"42097_CR22","doi-asserted-by":"publisher","first-page":"206","DOI":"10.3390\/cancers15010206","volume":"15","author":"T Karjula","year":"2023","unstructured":"Karjula, T. et al. CD3 + and CD8 + T-Cell-Based Immune Cell Score and PD-(L)1 Expression in Pulmonary Metastases of Microsatellite Stable Colorectal Cancer. Cancers (Basel). 15(1), 206\u201322 (2023).","journal-title":"Cancers (Basel)."},{"issue":"10135","key":"42097_CR23","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1016\/S0140-6736(18)30789-X","volume":"391","author":"F Pag\u00e8s","year":"2018","unstructured":"Pag\u00e8s, F. et al. International validation of the consensus Immunoscore for the classification of colon cancer: A prognostic and accuracy study. Lancet 391(10135), 2128\u201339 (2018).","journal-title":"Lancet"},{"key":"42097_CR24","doi-asserted-by":"crossref","unstructured":"Fujiyoshi K, Bruford EA, Mroz P, Sims CL, O\u2019Leary TJ, Lo AWI, et al. Standardizing gene product nomenclature-a call to action. Proc Natl Acad Sci USA 118(3) (2021).","DOI":"10.1073\/pnas.2025207118"},{"key":"42097_CR25","doi-asserted-by":"crossref","unstructured":"Bankhead P, Loughrey MB, Fern\u00e1ndez JA, Dombrowski Y, McArt DG, Dunne PD, et al. QuPath: Open source software for digital pathology image analysis. Sci Rep. ;7(1) (2017).","DOI":"10.1038\/s41598-017-17204-5"},{"key":"42097_CR26","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin, J. et al. Fiji: An open-source platform for biological-image analysis. Nat. Methods 9, 676\u201382 (2012).","journal-title":"Nat. Methods"},{"key":"42097_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.csda.2013.07.015","volume":"69","author":"M Rota","year":"2014","unstructured":"Rota, M. & Antolini, L. Finding the optimal cut-point for Gaussian and Gamma distributed biomarkers. Comput. Stat. Data Anal. 69, 1\u201314 (2014).","journal-title":"Comput. Stat. Data Anal."},{"issue":"5","key":"42097_CR28","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1002\/bjs.6930","volume":"97","author":"JN Armitage","year":"2010","unstructured":"Armitage, J. N. & Van Der Meulen, J. H. Identifying co-morbidity in surgical patients using administrative data with the Royal College of Surgeons Charlson Score. British Journal of Surgery 97(5), 772\u201381 (2010).","journal-title":"British Journal of Surgery"},{"issue":"3","key":"42097_CR29","doi-asserted-by":"publisher","first-page":"998","DOI":"10.4143\/crt.2015.254","volume":"48","author":"SH Kim","year":"2016","unstructured":"Kim, S. H. et al. What is the ideal tumor regression grading system in rectal cancer patients after preoperative chemoradiotherapy?. Cancer Res Treat 48(3), 998 (2016).","journal-title":"Cancer Res Treat"},{"key":"42097_CR30","doi-asserted-by":"crossref","unstructured":"Gkikas A, Kakos C, Lampridis S, Godolphin PJ, Patrini D. Preoperative prognostic factors for 5-year survival following pulmonary metastasectomy from colorectal cancer: a systematic review and meta-analysis. Eur. J. Cardio-Thoracic Surgery 63(3) (2023).","DOI":"10.1093\/ejcts\/ezad059"},{"issue":"1","key":"42097_CR31","doi-asserted-by":"publisher","first-page":"267","DOI":"10.7150\/jca.27507","volume":"10","author":"W Ma","year":"2019","unstructured":"Ma, W. et al. High expression of indoleamine 2, 3-dioxygenase in adenosquamous lung carcinoma correlates with favorable patient outcome. J Cancer 10(1), 267\u201376 (2019).","journal-title":"J Cancer"},{"issue":"1","key":"42097_CR32","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1002\/ijc.25979","volume":"130","author":"J Jacquemier","year":"2012","unstructured":"Jacquemier, J. et al. High expression of indoleamine 2,3-dioxygenase in the tumour is associated with medullary features and favourable outcome in basal-like breast carcinoma. Int J Cancer. 130(1), 96\u2013104 (2012).","journal-title":"Int J Cancer."},{"issue":"12","key":"42097_CR33","doi-asserted-by":"publisher","first-page":"3726","DOI":"10.1111\/cas.13811","volume":"109","author":"S Li","year":"2018","unstructured":"Li, S. et al. Mechanism and prognostic value of indoleamine 2,3-dioxygenase 1 expressed in hepatocellular carcinoma. Cancer Sci. 109(12), 3726\u201336 (2018).","journal-title":"Cancer Sci."},{"issue":"2","key":"42097_CR34","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.ygyno.2009.07.015","volume":"115","author":"T Inaba","year":"2009","unstructured":"Inaba, T. et al. Role of the immunosuppressive enzyme indoleamine 2,3-dioxygenase in the progression of ovarian carcinoma. Gynecol Oncol 115(2), 185\u201392 (2009).","journal-title":"Gynecol Oncol"},{"issue":"3","key":"42097_CR35","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1111\/j.1440-1746.2003.03259.x","volume":"19","author":"T Ishio","year":"2004","unstructured":"Ishio, T. et al. Immunoactivative role of indoleamine 2,3-dioxygenase in human hepatocellular carcinoma. Journal of Gastroenterology and Hepatology 19(3), 319\u201326 (2004).","journal-title":"Journal of Gastroenterology and Hepatology"},{"key":"42097_CR36","doi-asserted-by":"crossref","unstructured":"Zeng Z, Yang F, Wang Y, Zhao H, Wei F, Zhang P, et al. Significantly different immunoscores in lung adenocarcinoma and squamous cell carcinoma and a proposal for a new immune staging system. Oncoimmunology 9(1) (2020).","DOI":"10.1080\/2162402X.2020.1828538"},{"issue":"5","key":"42097_CR37","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1111\/bjd.13100","volume":"171","author":"I Chevolet","year":"2017","unstructured":"Chevolet, I. et al. Peritumoral indoleamine 2,3-dioxygenase expression in melanoma: An early marker of resistance to immune control?. Br. J. Dermatol. 171(5), 987\u201395 (2017).","journal-title":"Br. J. Dermatol."},{"issue":"23","key":"42097_CR38","doi-asserted-by":"publisher","first-page":"4883","DOI":"10.1158\/1078-0432.CCR-23-1928","volume":"29","author":"A Bessede","year":"2023","unstructured":"Bessede, A. et al. Upregulation of indoleamine 2,3-dioxygenase 1 in tumor cells and tertiary lymphoid structures is a hallmark of inflamed non\u2013small cell lung cancer. Clin. Cancer Res. 29(23), 4883\u201393 (2023).","journal-title":"Clin. Cancer Res."},{"key":"42097_CR39","doi-asserted-by":"crossref","unstructured":"Loeser H, Kraemer M, Gebauer F, Bruns C, Schr\u00f6der W, Zander T, et al. Indoleamine 2,3-Dioxygenase (IDO) Expression Is an Independent Prognostic Marker in Esophageal Adenocarcinoma. J. Immunol. Res. (2020).","DOI":"10.1155\/2020\/2862647"},{"key":"42097_CR40","doi-asserted-by":"crossref","unstructured":"Wang M, Deng C, Yang C, Yan M, Lu H, Zhang Y, et al. Unraveling temporal and spatial biomarkers of epithelial-mesenchymal transition in colorectal cancer: insights into the crucial role of immunosuppressive cells. J Transl Med. 21(1) (2023).","DOI":"10.1186\/s12967-023-04600-x"},{"issue":"12","key":"42097_CR41","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1158\/1541-7786.MCR-10-0568","volume":"9","author":"D Yao","year":"2011","unstructured":"Yao, D., Dai, C. & Peng, S. Mechanism of the mesenchymal-epithelial transition and its relationship with metastatic tumor formation. Mol. Cancer Res. 9(12), 1608\u201320 (2011).","journal-title":"Mol. Cancer Res."},{"key":"42097_CR42","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.ccell.2016.09.011","volume":"30","author":"Y Liu","year":"2016","unstructured":"Liu, Y. & Cao, X. Characteristics and Significance of the Pre-metastatic Niche. Cancer Cell. 30, 668\u201381 (2016).","journal-title":"Cancer Cell."},{"key":"42097_CR43","doi-asserted-by":"crossref","unstructured":"Panda A, Ganesan S. Genomic and Immunologic Correlates of Indoleamine 2,3-Dioxygenase Pathway Expression in Cancer. Front Genet. 12 (2021).","DOI":"10.3389\/fgene.2021.706435"},{"issue":"11","key":"42097_CR44","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1038\/modpathol.2016.139","volume":"29","author":"LH Lee","year":"2016","unstructured":"Lee, L. H. et al. Patterns and prognostic relevance of PD-1 and PD-L1 expression in colorectal carcinoma. Modern Pathol. 29(11), 1433\u201342 (2016).","journal-title":"Modern Pathol."},{"issue":"2","key":"42097_CR45","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1177\/1724600818817320","volume":"34","author":"YS Ko","year":"2019","unstructured":"Ko, Y. S. & Pyo, J. S. Clinicopathological significance and prognostic role of tumor-infiltrating lymphocytes in colorectal cancer. Int. J. Biol. Markers 34(2), 132\u20138 (2019).","journal-title":"Int. J. Biol. Markers"},{"issue":"7948","key":"42097_CR46","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/s41586-022-05680-3","volume":"614","author":"E Karimi","year":"2023","unstructured":"Karimi, E. et al. Single-cell spatial immune landscapes of primary and metastatic brain tumours. Nature 614(7948), 555\u201363 (2023).","journal-title":"Nature"},{"key":"42097_CR47","doi-asserted-by":"crossref","unstructured":"Zou Y, Ye F, Kong Y, Hu X, Deng X, Xie J, et al. The Single-Cell Landscape of Intratumoral Heterogeneity and The Immunosuppressive Microenvironment in Liver and Brain Metastases of Breast Cancer. Adv. Sci. 10(5) (2023).","DOI":"10.1002\/advs.202203699"},{"key":"42097_CR48","doi-asserted-by":"crossref","unstructured":"Herrera-Rios D, Mughal SS, Teuber-Hanselmann S, Pierscianek D, Sucker A, Jansen P, et al. Macrophages\/Microglia Represent the Major Source of Indolamine 2,3-Dioxygenase Expression in Melanoma Metastases of the Brain. Front Immunol. 11 (2020).","DOI":"10.3389\/fimmu.2020.00120"},{"key":"42097_CR49","doi-asserted-by":"crossref","unstructured":"Zou Y, Hu X, Zheng S, Yang A, Li X, Tang H, et al. Discordance of immunotherapy response predictive biomarkers between primary lesions and paired metastases in tumours: a multidimensional analysis. EBioMedicine 63 (2021).","DOI":"10.1016\/j.ebiom.2020.103137"},{"key":"42097_CR50","doi-asserted-by":"crossref","unstructured":"Yeap WH, Wong KL, Shimasaki N, Teo ECY, Quek JKS, Yong HX, et al. CD16 is indispensable for antibodydependent cellular cytotoxicity by human monocytes. Sci Rep. 6 (2016).","DOI":"10.1038\/srep34310"},{"key":"42097_CR51","doi-asserted-by":"crossref","unstructured":"Junker F, Gordon J, Qureshi O. Fc Gamma Receptors and Their Role in Antigen Uptake, Presentation, and T Cell Activation. Front. Immunol. Front. Media 11 (2020).","DOI":"10.3389\/fimmu.2020.01393"},{"issue":"2","key":"42097_CR52","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1002\/JLB.4RI0818-311R","volume":"106","author":"CE Olingy","year":"2019","unstructured":"Olingy, C. E., Dinh, H. Q. & Hedrick, C. C. Monocyte heterogeneity and functions in cancer. J. Leukoc Biol. 106(2), 309\u201322 (2019).","journal-title":"J. Leukoc Biol."},{"key":"42097_CR53","doi-asserted-by":"crossref","unstructured":"Kapellos TS, Bonaguro L, Gem\u00fcnd I, Reusch N, Saglam A, Hinkley ER, et al. Human monocyte subsets and phenotypes in major chronic inflammatory diseases. Front. Immunol. (2019).","DOI":"10.3389\/fimmu.2019.02035"},{"issue":"11","key":"42097_CR54","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1038\/s43018-022-00447-1","volume":"3","author":"I Yofe","year":"2022","unstructured":"Yofe, I. et al. Anti-CTLA-4 antibodies drive myeloid activation and reprogram the tumor microenvironment through Fc\u03b3R engagement and type I interferon signaling. Nat. Cancer 3(11), 1336\u201350 (2022).","journal-title":"Nat. Cancer"},{"key":"42097_CR55","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1307873","author":"S Nersesian","year":"2023","unstructured":"Nersesian, S. et al. Improved overall survival in patients with high-grade serous ovarian cancer is associated with CD16a+ immunologic neighborhoods containing NK cells, T cells and macrophages. Front. Immunol. https:\/\/doi.org\/10.3389\/fimmu.2023.1307873 (2023).","journal-title":"Front. Immunol."},{"issue":"11","key":"42097_CR56","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.1002\/ijc.25609","volume":"128","author":"G Sconocchia","year":"2011","unstructured":"Sconocchia, G. et al. Tumor infiltration by FcI\u03b3RIII (CD16)+ myeloid cells is associated with improved survival in patients with colorectal carcinoma. Int. J. Cancer 128(11), 2663\u201372 (2011).","journal-title":"Int. J. Cancer"},{"key":"42097_CR57","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01147","author":"AE Mengos","year":"2019","unstructured":"Mengos, A. E., Gastineau, D. A. & Gustafson, M. P. The CD14\u2009+\u2009HLA-DrlO\/NEG monocyte: An immunosuppressive phenotype that restrains responses to cancer immunotherapy. Front. Immunol. https:\/\/doi.org\/10.3389\/fimmu.2019.01147 (2019).","journal-title":"Front. Immunol."},{"key":"42097_CR58","doi-asserted-by":"crossref","unstructured":"V\u00e4yrynen JP, Haruki K, V\u00e4yrynen SA, Lau MC, Dias Costa A, Borowsky J, et al. Prognostic significance of myeloid immune cells and their spatial distribution in the colorectal cancer microenvironment. J. Immunother Cancer. 9(4) (2021).","DOI":"10.1136\/jitc-2020-002297"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-42097-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-42097-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-42097-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T09:54:06Z","timestamp":1775728446000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-42097-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,2]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["42097"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-42097-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7420974\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,2]]},"assertion":[{"value":"20 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"T.T.S. declares consultation fee from Amgen Finland. T.T.S is CEO and co-owner of Healthfund Finland and Clinical Advisory board member of LS Cancer Diag. The other authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The Oulu University Hospital Ethics Committee (EETMK 152\/2008) approved the study. The Finnish National Authority of Medicolegal Affairs (VALVIRA) waived the need for informed consent due to the retrospective nature of the study. The study was performed in accordance with the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"11770"}}